Skip to content

Clinical trials

Completed Hepatitis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Status: Completed Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20092
20111
20131
20152
20181
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Brii Biosciences Limited2
Gilead Sciences2
Novartis Pharmaceuticals2
Peking University1
Sanofi Pasteur, a Sanofi Company1
The First Hospital of Jilin University1
University of North Carolina, Chapel Hill1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis13
Hepatitis B7
Hepatitis B, Chronic7
Hepatitis, Chronic3
Hepatitis C2
DNA Virus Infections1
Digestive System Diseases1
Fibrosis1
Hematologic Diseases1
Hepatitis A1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.